Description
It’s likely that no single factor has the potential to be as financially disruptive to the clinical laboratory industry as the impending repricing of the Medicare Part B clinical laboratory fee schedule (CLFS). Learn how to effectively prepare for the negative financial impact of Medicare cuts, and what you need to do today to protect your lab against lost revenue and guard its market share!
